x

AXIM BIOTECHNOLOGIES, INC. (OTC:AXIM)

Health Care/Life Sciences • Biotechnology
CIK 1514946
Company

AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.

Address
6191 Cornerstone Court East
Suite 114
San Diego, California 92121
Employees
9
Stock Info
Close
$0.0176
Day Range
0.0160 - 0.0170
52 Week Range
0.0130 - 0.0600
Average volume
342.04K
Short Interest
N/A (N/A)
% of Float Shorted
N/A
Market Cap
$4.18M
Revenue
$8.88K
Net Income
-$6.24M
2020 Sales Growth
N/A
Rev. per Employee
$3,829.7800
P/E Ratio
N/A
EPS
-$0.0333
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
John W Huemoeller II
Director
Blake N Schroeder
Director
Peter M O'Rourke Sr.
Independent Director
Timothy R Scott PhD
Independent Director
Robert L Cunningham
SEC filings
DateFormEvent
6 Dec, 2024 15-12G
13 Nov, 2024 NT 10-Q
15 Oct, 2024 8-K
15 Oct, 2024 4
19 Aug, 2024 10-Q
13 Aug, 2024 NT 10-Q
22 May, 2024 10-Q/A
20 May, 2024 10-Q
15 May, 2024 NT 10-Q
16 Apr, 2024 10-K
1 Apr, 2024 NT 10-K
21 Mar, 2024 8-K
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4
19 Mar, 2024 4/A
13 Feb, 2024 8-K
28 Dec, 2023 8-K
20 Nov, 2023 10-Q
14 Nov, 2023 NT 10-Q
21 Sep, 2023 DEF 14C
31 Aug, 2023 PRE 14C
21 Aug, 2023 10-Q
14 Aug, 2023 NT 10-Q
9 Jun, 2023 EFFECT
7 Jun, 2023 UPLOAD
7 Jun, 2023 CORRESP
2 Jun, 2023 8-K
2 Jun, 2023 S-1
30 May, 2023 8-K
30 May, 2023 3
25 May, 2023 8-K CEO Change
22 May, 2023 10-Q
15 May, 2023 NT 10-Q
17 Apr, 2023 10-K
31 Mar, 2023 NT 10-K
27 Jan, 2023 8-K
15 Nov, 2022 10-Q/A
14 Nov, 2022 10-Q
7 Oct, 2022 144
23 Sep, 2022 4
23 Sep, 2022 3
23 Sep, 2022 3
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 4
23 Sep, 2022 SC 13D
19 Sep, 2022 8-K
31 Aug, 2022 3
31 Aug, 2022 4
31 Aug, 2022 3
31 Aug, 2022 SC 13D/A
31 Aug, 2022 SC 13D
31 Aug, 2022 SC 13D
29 Aug, 2022 8-K
26 Aug, 2022 4
16 Aug, 2022 10-Q
16 Aug, 2022 NT 10-Q
4 Aug, 2022 EFFECT
2 Aug, 2022 S-1/A
2 Aug, 2022 CORRESP
29 Jul, 2022 UPLOAD
25 Jul, 2022 S-1
14 Jun, 2022 S-8
23 May, 2022 10-Q
17 May, 2022 NT 10-Q
19 Apr, 2022 10-K/A
15 Apr, 2022 10-K
31 Mar, 2022 NT 10-K
9 Mar, 2022 8-K
16 Feb, 2022 8-K
15 Feb, 2022 4
12 Jan, 2022 8-K
7 Jan, 2022 8-K
22 Nov, 2021 10-Q
15 Nov, 2021 NT 10-Q
23 Aug, 2021 10-Q
16 Aug, 2021 NT 10-Q
4 Aug, 2021 8-K
22 Jun, 2021 EFFECT
21 Jun, 2021 CORRESP
9 Jun, 2021 S-1/A
2 Jun, 2021 10-Q/A
24 May, 2021 10-Q
19 May, 2021 UPLOAD
14 May, 2021 NT 10-Q
14 May, 2021 8-K
14 May, 2021 S-1
26 Apr, 2021 10-K/A
15 Apr, 2021 10-K
30 Mar, 2021 NT 10-K
Last update:2024-03-06 12:27:52.996151
AXIM BIOTECHNOLOGIES, INC. by TradingView

Sign Up to Subscribe